A detailed history of Janus Henderson Group PLC transactions in Catalent, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 3,094,620 shares of CTLT stock, worth $186 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
3,094,620
Previous 9,560,698 67.63%
Holding current value
$186 Million
Previous $540 Million 67.76%
% of portfolio
0.1%
Previous 0.3%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$53.58 - $57.02 $346 Million - $369 Million
-6,466,078 Reduced 67.63%
3,094,620 $174 Million
Q1 2024

May 15, 2024

SELL
$42.56 - $59.82 $157 Million - $221 Million
-3,688,641 Reduced 27.84%
9,560,698 $540 Million
Q4 2023

Feb 14, 2024

SELL
$32.18 - $46.57 $51.8 Million - $75 Million
-1,609,885 Reduced 10.83%
13,249,339 $595 Million
Q3 2023

Nov 14, 2023

BUY
$44.2 - $50.2 $5.38 Million - $6.11 Million
121,789 Added 0.83%
14,859,224 $677 Million
Q2 2023

Aug 14, 2023

BUY
$31.86 - $67.26 $86.7 Million - $183 Million
2,720,949 Added 22.64%
14,737,435 $639 Million
Q1 2023

May 15, 2023

BUY
$45.44 - $74.26 $173 Million - $282 Million
3,800,244 Added 46.25%
12,016,486 $790 Million
Q4 2022

Feb 14, 2023

BUY
$41.39 - $81.0 $58.1 Million - $114 Million
1,402,579 Added 20.58%
8,216,242 $370 Million
Q3 2022

Nov 14, 2022

SELL
$72.36 - $113.1 $15.2 Million - $23.8 Million
-210,135 Reduced 2.99%
6,813,663 $493 Million
Q2 2022

Aug 15, 2022

SELL
$87.2 - $114.05 $50.8 Million - $66.4 Million
-582,432 Reduced 7.66%
7,023,798 $754 Million
Q1 2022

May 16, 2022

SELL
$94.19 - $124.49 $113 Million - $150 Million
-1,203,939 Reduced 13.67%
7,606,230 $844 Million
Q4 2021

Feb 14, 2022

SELL
$119.57 - $139.07 $12.6 Million - $14.7 Million
-105,454 Reduced 1.18%
8,810,169 $1.13 Billion
Q3 2021

Nov 16, 2021

SELL
$109.17 - $142.35 $39.9 Million - $52 Million
-365,509 Reduced 3.94%
8,915,623 $1.19 Billion
Q2 2021

Aug 16, 2021

SELL
$100.34 - $115.69 $101 Million - $116 Million
-1,006,038 Reduced 9.78%
9,281,132 $1 Billion
Q1 2021

May 17, 2021

SELL
$101.51 - $125.27 $168 Million - $208 Million
-1,658,318 Reduced 13.88%
10,287,170 $1.08 Billion
Q4 2020

Feb 16, 2021

SELL
$85.88 - $105.36 $101 Million - $124 Million
-1,179,849 Reduced 8.99%
11,945,488 $1.24 Billion
Q3 2020

Nov 16, 2020

SELL
$72.74 - $92.5 $133 Million - $169 Million
-1,824,551 Reduced 12.2%
13,125,337 $1.12 Billion
Q2 2020

Aug 14, 2020

SELL
$48.02 - $79.04 $39 Million - $64.2 Million
-812,060 Reduced 5.15%
14,949,888 $1.1 Billion
Q1 2020

May 14, 2020

SELL
$36.95 - $62.95 $27.9 Million - $47.5 Million
-755,253 Reduced 4.57%
15,761,948 $819 Million
Q4 2019

Feb 18, 2020

SELL
$47.06 - $56.64 $5.02 Million - $6.04 Million
-106,671 Reduced 0.64%
16,517,201 $930 Million
Q3 2019

Nov 14, 2019

SELL
$47.45 - $58.05 $31.8 Million - $38.9 Million
-670,388 Reduced 3.88%
16,623,872 $792 Million
Q2 2019

Jul 31, 2019

SELL
$39.26 - $54.21 $8.2 Million - $11.3 Million
-208,963 Reduced 1.19%
17,294,260 $938 Million
Q1 2019

Apr 30, 2019

BUY
$29.84 - $43.92 $78.2 Million - $115 Million
2,620,352 Added 17.61%
17,503,223 $710 Million
Q4 2018

Feb 06, 2019

BUY
$29.95 - $46.34 $229 Million - $354 Million
7,648,210 Added 105.72%
14,882,871 $464 Million
Q3 2018

Nov 09, 2018

BUY
$40.12 - $45.55 $33.5 Million - $38 Million
833,924 Added 13.03%
7,234,661 $330 Million
Q2 2018

Aug 10, 2018

BUY
$38.72 - $42.52 $10.3 Million - $11.3 Million
266,183 Added 4.34%
6,400,737 $268 Million
Q1 2018

May 14, 2018

SELL
$39.4 - $47.39 $5.94 Million - $7.15 Million
-150,832 Reduced 2.4%
6,134,554 $252 Million
Q4 2017

Feb 09, 2018

SELL
$37.27 - $43.02 $6.54 Million - $7.55 Million
-175,491 Reduced 2.72%
6,285,386 $258 Million
Q3 2017

Nov 14, 2017

SELL
$33.75 - $41.67 $12.4 Million - $15.3 Million
-366,168 Reduced 5.36%
6,460,877 $0
Q2 2017

Aug 17, 2017

BUY
N/A
6,827,045
6,827,045 $240 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.8B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.